Activation of the mononuclear phagocyte system by poloxamine 908: Its implications for targeted drug delivery

Pharmaceutical Research

Volumn 14, Issue 11, 1997, Pages 1629-1633

  Armstrong, T I ^a   Moghimi, S M ^a   Davis, S S ^a   Illum, L ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Mononuclear phagocyte system; Nanoparticle; Poloxamine 908; Targeted drug delivery

Indexed keywords

IODINE 125; POLYMER; POLYSTYRENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DOSE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; KUPFFER CELL; MONONUCLEAR PHAGOCYTE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT;

ANIMALS; BIOLOGICAL AVAILABILITY; DRUG ADMINISTRATION SCHEDULE; DRUG CARRIERS; ETHYLENEDIAMINES; MACROPHAGE ACTIVATION; MALE; MONOCYTES; OPSONIN PROTEINS; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 0031442497     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012194721763     Document Type: Article

References (30)

1. L. Illum, S. S. Davis, R. H. Müller, E. Mak and P. West. Life Sci. 40:367-374 (1987).
2. S. E. Dunn, A. Brindley, S. S. Davis, M. C. Davies, and L. Illum. Pharm. Res. 11:1016-1022 (1994).
3. S. M. Moghimi, C. J. H. Porter, I. S. Muir, L. Illum, and S. S. Davis. Biochem. Biophys. Res. Commun. 177:861-866 (1991).
4. S. M. Moghimi, H. Hedeman, I. S. Muir, L. Illum, and S. S. Davis. Biochim. Biophys. Acta 1157:233-240 (1993).
5. S. M. Moghimi, H. Hedeman, N. M. Christy, L. Illum, and S. S. Davis. J. Leukocyte Biol. 54:513-517 (1993).
6. H. Hedeman. A colloidal system for targeting of the spleen. MSc Thesis. The Royal Danish School of Pharmacy, Copenhagen, Denmark (1992).
7. N. B. Argent, J. Liles, D. Rodham, C. B. Clayton, R. Wilkinson, and P. H. Baylis. Laboratory Animals 28:172-175 (1994).
8. T. I. Armstrong, M. C. Davies, and L. Illum. J. Drug Targeting 4:389-398 (1997).
9. N. M. Christy, S. M. Moghimi, L. Illum, and S. S. Davis. Proc. Intern. Symp. Control. Rel. Bioact. Mater. 19:355-356 (1992).
10. R. Tarsi, F. Mulieri, F. Venturi, and N. Simonetti. J. Leukocyte Biol. 37:45-50 (1985).
11. T. M. Saba and Antilatzides. Br. J. Cancer 32:471-482 (1975).
12. E. R. Abril, C. Jolley, and D. L. Earnest. Gastroenterol. 106:A855 (1994).
13. R. M. J. Hoedemakers, P. J. M. Vossebeld, T. Daemen, and G. L. Scherphof. J. Immunother. 13:252-260 (1993).
14. M. J. Thomassen, D. P. Meeker, S. D. Deodhar, H. P. Wiedemann, and B. P. Barna. J. Immunother. 13:1-6 (1993).
15. L. S. Feder and D. L. Laskin. J. Leukocyte. Biol. 55:507-513 (1994).
16. P. S. Richards and T. M. Saba. Hepatology 5:32-37 (1985).
17. M. Shirahama, H. Ishibashi, Y. Tsuchiya, S. Kurokawa, K. Kurokawa, Y. Hayashida, and Y. Niho. Scand. J. Immunol. 28:719-725 (1988).
18. T. Yamaoka, Y. Tabata, and Y. Ikada. J. Pharm. Sci. 83:601-606 (1994).
19. T. P. Johnston, H. Beris, Z. G. Wout, and J. L. Kennedy. Int. J. Pharm. 100:279-284 (1993).
20. J. G. Raynes. Biochem. Soc. Trans. 22:69-74 (1994).
21. S. Thiel, U. Holmskov, L. Hvid, S. B. Laursen, and J. C. Jensenius. Clin. Exp. Immunol. 90:31-35 (1992).
22. S. Larrson, U. Thelander, and S. Friberg. Clin. Orthop. Relat. Res. 275:237-242 (1992).
23. Y. Aramaki, M. Murai, and S. Tsuchiya. Pharm. Res. 11:518-521 (1994).
24. S. M. Moghimi and S. S. Davis. CRC Crit. Rev. Ther. Drug Carrier System 11:31-59 (1994).
25. S. M. Moghimi, H. Hedeman, L. Illum, and S. S. Davis. Clin. Sci. 84:605-609 (1993).
26. A. A. Knowlton, C. M. Connelly, G. M. Romo, W. Mamuya, C. S. Apstein, and P. Brecher. J. Clin. Invest. 89:1060-1068 (1992).
27. T. Konzaki, Y. Saito, S. Yashimo, S. Murano, and N. Mariski. LANCA 339:1244 (1992).
28. T. Bainbridge and R. Fick. J. Lab. Clin. Med. 114:728-733 (1989).
29. V. Najjar and A. Constantopoulos. J. Reticuloendothel. Soc. 12:197-215 (1972).
30. J. Webb and K. Whaley. Aust. NZ J. Med. 16:268-278 (1986).